We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,093

News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


USPTO's Patent Subject Matter Eligibility Roundtable on Dec. 5, 2015
  • Fenwick & West LLP
  • USA
  • December 1 2016

On December 5, 2016 the USPTO will hold its second Patent Subject Matter Eligibility Roundtable to discuss issues in patent eligibility. The USPTO


State AGs in the news
  • Dickstein Shapiro LLP
  • USA
  • July 24 2014

CWAG held its annual meeting this week in Park City, Utah, which was attended by several members of Dickstein Shapiro's State Attorneys General


Election analysis
  • Arent Fox LLP
  • OECD, USA
  • November 9 2016

This election has produced a stunning result surprising the pundits, pollsters and many Americans. Despite the often


Expect focus - volume III, Summer 2014
  • Carlton Fields
  • USA
  • September 16 2014

EXPECTFOCUS is a quarterly review of developments in the insurance and financial services industry, provided on a complimentary basis to clients and


Supreme Court on health reform and patent case budget transportation programs FCC reform cybersecurity
  • Locke Lord LLP
  • USA
  • April 5 2012

With a two-week recess looming and the 2012 elections coming ever more into focus, Congress addressed a temporary fix on a critical deadline and set the stage for the budget debate, tax reform and other key considerations to be taken up over the Spring and Summer as it completed its most recent work period late last week


Life sciences & medical technology newsletter, Fall 2013 - Winter 2014
  • Greenberg Traurig LLP
  • USA
  • January 10 2014

On September 25, 2013, the U.S. Food and Drug Administration (the "FDA") released final guidance on the regulatory requirements regarding the


Patent strategies in the digital health care space
  • Fenwick & West LLP
  • USA
  • July 13 2015

You are founding a startup with a great new idea to revolutionize a key health care segment, but you know the digital health space is packed with


Copyright for Engineered DNA
  • GQ Life Sciences
  • USA
  • February 23 2016

With the United States Supreme Court ruling in Myriad,the enforceability of certain claims in existing gene patents and the broader patentability of


ClearCorrect: ITC and Patentee Align Submit Petitions for Rehearing En Banc, Asking Federal Circuit to Reconsider Whether the ITC Has Jurisdiction Over Digital Imports
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • January 29 2016

On January 27, 2016, the International Trade Commission (ITC) formally requested a rehearing en banc of a November 10, 2015, Federal Circuit panel